Executive Board

Professor Duncan Jodrell, DM MSc FRCP(Edin.) – Co Director, Researcher and Medical Oncologist

Duncan is the Professor of Cancer Therapeutics at the University of Cambridge and a Senior Group Leader at the Cancer Research UK Cambridge Institute. He is also the Cambridge Experimental Cancer Medicine Centre (ECMC) Lead, Director of the Cambridge Cancer Trials Centre (CCTC) and an honorary consultant at Addenbrooke’s Hospital.

Professor Ashok Venkitaraman Co Director, Ursula Zoellner Professor; Director, MRC Cancer Cell Unit

Ashok Venkitaraman holds the Ursula Zoellner Professorship of Cancer Research at the University of Cambridge, and is the Director of the Medical Research Council (MRC) Cancer Cell Unit. He leads a multidisciplinary initiative that aims to pioneer new approaches for chemical biology and the development of small-molecule therapeutics.

Aarthi Gopinathan – Pancreatic Cancer Programme Manager

Aarthi Gopinathan did her doctoral thesis work in Professor Tuveson’s laboratory at the University of Pennsylvania and the Cancer Research UK – Cambridge Research Institute. Since then, she has worked on pancreatic cancer drug development, clinical and translational research.

Bristi Basu – Cancer Research UK Medical Oncologist and Patient Liaison

Dr Bristi Basu is an academic consultant in medical oncology, specialising in experimental cancer therapeutics in the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. She trained in Medicine at Oxford University (Prosser Exhibitions) before undertaking clinical speciality training in Medical Oncology at Cambridge.

Gerald Coteman – Director of Community Engagement

Gerald has a background in health going back to the early 1980s when he joined the Board of the then Cambridge Health Authority. He subsequently became a Board Director of North Herts NHS Trust, based at the Lister Hospital, and joined the Addenbrooke’s NHS Trust Board in 1999. With the advent of NHS Foundation Trusts, he was appointed to the Board of Cambridge University Hospitals Foundation Trust in 2004.

Dr Martin L Miller MSc PhD

Martin is a Junior Group Leader at the Cancer Research UK Cambridge Institute. His research is focused on cell-cell interactions in the tumour microenvironment and unravelling stroma-mediated drug resistance in human cancers using proteomic technologies.

Dr. Nicholas Carroll – Radiologist

Nick Carroll is a consultant gastrointestinal radiologist specialising in endoscopic ultrasound. He is a member of the BSGAR and ESGAR and has published on EUS in pancreatic disease and combined EUS and EBUS for lung cancer staging.

Dr Pippa Corrie PhD FRCP – Consultant and Associate Lecturer in Medical Oncology

Pippa Corrie established the Cambridge Cancer Trials Centre, led one of the first wave NCRN regional research networks and is now NIHR Clinical Research Network National Specialty Lead for Cancer: Late Phase and International Cancer Trials, as well as Cancer Specialty Lead for the NIHR Eastern Clinical Research Network.

Dr. Rebecca Brais – Pathologist

Rebecca Brais is a Consultant Histopathologist at Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust. She is currently involved in numerous collaborative research projects and trials including the first national trial on neuroendocrine tumours of the pancreas.

Mr Siong-Seng Liau, Consultant Hepatobiliary and Pancreatic Surgeon, Addenbrooke’s Hospital, Clinician Scientist, Honorary Senior Research Fellow, MRC Cancer Unit

Mr Liau is a Consultant Hepatopancreatobiliary Surgeon with a clinical interest in Advanced Minimally-invasive Hepatobiliary and Pancreatic Surgery. Concurrently, he was an MRC-Academy of Medical Sciences Clinician Scientist at the MRC Cancer Unit and University Department of Surgery, Addenbrooke's Hospital, Cambridge.

People: Executive Board